13F

Stock

Allogene Therapeutics, Inc.

ALLO · held by 2 managers

Reported value

$961.3K

Holders

2

+0 new · −0 exited

Holders’ est. mark

$80.2K

Price effect on 2 books still in the name

Largest holder

$960.3K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC343K$960.3K$80KAdded$563.7K
Leonteq Securities AG351$983$165Added$165

Positions as of Q3 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.